Milton H. Werner - 07 Mar 2022 Form 4 Insider Report for Inhibikase Therapeutics, Inc. (IKT)

Role: President and CEO, Director, 10%+ Owner
Signature: /s/ Milton H. Werner
Issuer symbol: IKT
Transactions as of: 07 Mar 2022
Net transactions value: $0
Form type: 4
Filing time: 09 Mar 2022, 19:21:44 UTC
Previous filing: 04 Jan 2022
Next filing: 23 May 2022
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
holding	IKT	Common Stock						5,315,433	07 Mar 2022	Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Underlying Class	Amount	Exercise Price	Ownership	Footnotes
transaction	IKT	Stock Option (right to buy)	Award	$0	+125,000		$0.000000	125,000	07 Mar 2022	Common Stock	125,000	$1.07	Direct	F1

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	One-third of the options will vest and become exercisable on 3/7/2023, and the remaining portion will vest and become exercisable in 24 equal monthly installments commencing on the first day of April 2024, subject to continued employment through each such vesting date.